Nautilus Biotechnology Inc
NASDAQ:NAUT
Cash Flow Statement
Cash Flow Statement
Nautilus Biotechnology Inc
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(21)
|
(28)
|
(43)
|
(50)
|
(58)
|
(62)
|
(61)
|
(58)
|
(57)
|
(58)
|
(60)
|
(64)
|
(67)
|
(70)
|
(70)
|
(71)
|
(69)
|
(66)
|
(63)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
2
|
3
|
6
|
8
|
9
|
9
|
10
|
10
|
11
|
12
|
12
|
12
|
12
|
13
|
13
|
13
|
12
|
10
|
9
|
|
| Other Non-Cash Items |
4
|
5
|
8
|
10
|
11
|
12
|
12
|
12
|
12
|
12
|
13
|
13
|
14
|
14
|
14
|
15
|
14
|
13
|
12
|
|
| Change in Working Capital |
(1)
|
(1)
|
(3)
|
(0)
|
0
|
(2)
|
2
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
|
| Cash from Operating Activities |
(18)
N/A
|
(23)
-28%
|
(37)
-63%
|
(39)
-7%
|
(45)
-16%
|
(51)
-12%
|
(46)
+9%
|
(46)
+0%
|
(46)
0%
|
(46)
0%
|
(48)
-5%
|
(52)
-7%
|
(55)
-7%
|
(57)
-3%
|
(59)
-2%
|
(59)
-1%
|
(57)
+4%
|
(55)
+4%
|
(53)
+4%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
0
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(52)
|
(2)
|
(2)
|
(2)
|
48
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Other Items |
(9)
|
(47)
|
(131)
|
(137)
|
(145)
|
(25)
|
47
|
(23)
|
(52)
|
(89)
|
(15)
|
(41)
|
(5)
|
11
|
(60)
|
68
|
65
|
65
|
73
|
|
| Cash from Investing Activities |
(10)
N/A
|
(49)
-404%
|
(133)
-173%
|
(139)
-5%
|
(147)
-6%
|
(28)
+81%
|
44
N/A
|
(26)
N/A
|
(54)
-111%
|
(92)
-69%
|
(67)
+27%
|
(44)
+34%
|
(8)
+82%
|
9
N/A
|
(12)
N/A
|
66
N/A
|
63
-4%
|
64
+0%
|
72
+13%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other |
74
|
327
|
327
|
327
|
329
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
74
N/A
|
327
+343%
|
327
+0%
|
327
+0%
|
330
+1%
|
0
-100%
|
1
+19%
|
1
+12%
|
0
-29%
|
0
-20%
|
0
-22%
|
0
+47%
|
1
+67%
|
1
+36%
|
1
+14%
|
1
+20%
|
1
-20%
|
1
-24%
|
1
-20%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
47
N/A
|
256
+450%
|
158
-38%
|
149
-6%
|
137
-8%
|
(78)
N/A
|
(1)
+99%
|
(71)
-6 597%
|
(100)
-41%
|
(137)
-37%
|
(115)
+17%
|
(95)
+17%
|
(63)
+34%
|
(48)
+24%
|
(70)
-46%
|
8
N/A
|
8
-9%
|
10
+27%
|
19
+103%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(18)
N/A
|
(24)
-37%
|
(39)
-60%
|
(42)
-7%
|
(48)
-16%
|
(53)
-10%
|
(49)
+7%
|
(48)
+2%
|
(49)
-1%
|
(48)
+0%
|
(100)
-107%
|
(54)
+46%
|
(58)
-7%
|
(60)
-3%
|
(11)
+81%
|
(61)
-450%
|
(59)
+4%
|
(56)
+4%
|
(54)
+4%
|
|